(1)
No Harm from Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Inhibitors in Patients With COVID-19. Results of a Prospective Study on a Hospital-Based Cohort. Ital J Med 2020, 14 (3), 162-166. https://doi.org/10.4081/itjm.2020.1313.